These results suggest that elevated HMGA2 expression is associated with transformation of CIN into cervical cancer and that HMGA2 might be a useful biomarker for assessing the risk of cervical lesion progression. This evidence concerns the gene HMGA2 and cervical squamous intraepithelial neoplasia.